Docetaxel and paclitaxel are both chemotherapy drugs for tumors. Their differences include the following: 1. In terms of treatment, docetaxel is mainly more effective in advanced breast cancer, non-small cell lung cancer, head and neck cell cancer, gastric cancer, ovarian cancer, etc. Paclitaxel is more effective in ovarian cancer, breast cancer, and has some efficacy in the treatment of lung cancer, head and neck cancer, malignant melanoma, bladder cancer, etc. 2. In terms of toxic side effects, the main side effects of docetaxel include bone marrow suppression, allergic reaction, skin system lesions, fluid retention with edema, and cardiovascular and neurological damage, while the toxic side effects of paclitaxel are similar to those of docetaxel. During the treatment of intravenous drug, skin damage and inflammation may occur due to drug extravasation.